Literature DB >> 25232063

Fine-mapping of HLA associations with chronic lymphocytic leukemia in US populations.

Loren Gragert1, Stephanie Fingerson1, Mark Albrecht1, Martin Maiers1, Matt Kalaycio2, Brian T Hill2.   

Abstract

Chronic lymphocytic leukemia (CLL) displays remarkable ethnic predisposition for whites, with relative sparing of African-American and Asian populations. In addition, CLL displays among the highest familial predispositions of all hematologic malignancies, yet the genetic basis for these differences is not clearly defined. The highly polymorphic HLA genes of the major histocompatibility complex play a central role in immune surveillance and confer risk for autoimmune and infectious diseases and several different cancers, the role for which in the development of CLL has not been extensively investigated. The National Marrow Donor Program/Be The Match has collected HLA typing from CLL patients in need of allogeneic hematopoietic stem cell transplant and has recruited millions of volunteers to potentially donate hematopoietic stem cells. HLA genotypes for 3491 US white, 397 African-American, and 90 Hispanic CLL patients were compared with 50 000 controls per population from the donor registry. We identified several HLA alleles associated with CLL susceptibility in each population, reconfirming predisposing roles of HLA-A*02:01 and HLA-DRB4*01:01 in whites. Associations for haplotype DRB4*01:01∼DRB1*07:01∼DQB1*03:03 were replicated across all 3 populations. These findings provide a comprehensive assessment of the role of HLA in the development of severe CLL.
© 2014 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25232063      PMCID: PMC4208281          DOI: 10.1182/blood-2014-02-558767

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  52 in total

1.  Incidence of leukemia in Asian migrants to the United States and their descendants.

Authors:  Jenny W Y Pan; Linda S Cook; Stephen M Schwartz; Noel S Weis
Journal:  Cancer Causes Control       Date:  2002-11       Impact factor: 2.506

Review 2.  Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL.

Authors:  Tait D Shanafelt; Susan M Geyer; Neil E Kay
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

Review 3.  Causation of chronic lymphocytic leukemia--insights from familial disease.

Authors:  Richard S Houlston; Gabrielle Sellick; Martin Yuille; Estella Matutes; Daniel Catovsky
Journal:  Leuk Res       Date:  2003-10       Impact factor: 3.156

Review 4.  Natural killer cells, viruses and cancer.

Authors:  A Cerwenka; L L Lanier
Journal:  Nat Rev Immunol       Date:  2001-10       Impact factor: 53.106

5.  Major histocompatibility complex abnormalities in non-Hodgkin lymphomas.

Authors:  Bernard Drénou; Gaelle Le Friec; Marc Bernard; Céline Pangault; Jean-Marc Grosset; Thierry Lamy; Renée Fauchet; Laurence Amiot
Journal:  Br J Haematol       Date:  2002-11       Impact factor: 6.998

6.  Genomic aberrations and survival in chronic lymphocytic leukemia.

Authors:  H Döhner; S Stilgenbauer; A Benner; E Leupolt; A Kröber; L Bullinger; K Döhner; M Bentz; P Lichter
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

7.  Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack?

Authors:  Christian Demanet; Arend Mulder; Veronique Deneys; Maria J Worsham; Piet Maes; Frans H Claas; Soldano Ferrone
Journal:  Blood       Date:  2003-12-04       Impact factor: 22.113

8.  HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.

Authors:  Salim I Khakoo; Chloe L Thio; Maureen P Martin; Collin R Brooks; Xiaojiang Gao; Jacquie Astemborski; Jie Cheng; James J Goedert; David Vlahov; Margaret Hilgartner; Steven Cox; Ann-Margeret Little; Graeme J Alexander; Matthew E Cramp; Stephen J O'Brien; William M C Rosenberg; David L Thomas; Mary Carrington
Journal:  Science       Date:  2004-08-06       Impact factor: 47.728

9.  Increased frequency of homozygosity for HLA class II loci in female patients with chronic lymphocytic leukemia.

Authors:  L P Mueller; H K G Machulla
Journal:  Leuk Lymphoma       Date:  2002-05

Review 10.  The immunobiology of cancer immunosurveillance and immunoediting.

Authors:  Gavin P Dunn; Lloyd J Old; Robert D Schreiber
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

View more
  16 in total

1.  Reduced intensity conditioning regimens including alkylating chemotherapy do not alter survival outcomes after allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia compared to low-intensity non-myeloablative conditioning.

Authors:  Niels Smedegaard Andersen; Martin Bornhäuser; Martin Gramatzki; Peter Dreger; Antonin Vitek; Michal Karas; Mauricette Michallet; Carol Moreno; Michel van Gelder; Anja Henseler; Liesbeth C de Wreede; Stefan Schönland; Nicolaus Kröger; Johannes Schetelig
Journal:  J Cancer Res Clin Oncol       Date:  2019-08-29       Impact factor: 4.553

2.  Assessment of Impact of HLA Type on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia.

Authors:  Brian T Hill; Kwang Woo Ahn; Zhen-Huan Hu; Mahmoud Aljurf; Amer Beitinjaneh; Jean-Yves Cahn; Jan Cerny; Mohamed A Kharfan-Dabaja; Siddhartha Ganguly; Nilanjan Ghosh; Michael R Grunwald; Yoshihiro Inamoto; Tamila Kindwall-Keller; Taiga Nishihori; Richard F Olsson; Ayman Saad; Matthew Seftel; Sachiko Seo; Jeffrey Szer; Martin Tallman; Celalettin Ustun; Peter H Wiernik; Richard T Maziarz; Matt Kalaycio; Edwin Alyea; Uday Popat; Ronald Sobecks; Wael Saber
Journal:  Biol Blood Marrow Transplant       Date:  2017-10-12       Impact factor: 5.742

3.  Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLL.

Authors:  Gonzalo Blanco; Anna Vardi; Anna Puiggros; Andrea Gómez-Llonín; Manuel Muro; María Rodríguez-Rivera; Evangelia Stalika; Eugenia Abella; Eva Gimeno; Manuela López-Sánchez; Alicia Senín; Xavier Calvo; Pau Abrisqueta; Francesc Bosch; Ana Ferrer; Kostas Stamatopoulos; Blanca Espinet
Journal:  Oncoimmunology       Date:  2018-02-20       Impact factor: 8.110

4.  Asparaginase-induced hepatotoxicity: rapid development of cholestasis and hepatic steatosis.

Authors:  Natasha Kamal; Christopher Koh; Niharika Samala; Robert J Fontana; Andrew Stolz; Francisco Durazo; Paul H Hayashi; Elizabeth Phillips; Tongrong Wang; Jay H Hoofnagle
Journal:  Hepatol Int       Date:  2019-08-07       Impact factor: 6.047

5.  The association between HLA and non-Hodgkin lymphoma subtypes, among a transplant-indicated population.

Authors:  Charlie Zhong; Loren Gragert; Martin Maiers; Brian T Hill; Jean Garcia-Gomez; Ketevan Gendzekhadze; David Senitzer; Joo Song; Dennis Weisenburger; Leanne Goldstein; Sophia S Wang
Journal:  Leuk Lymphoma       Date:  2019-06-19

6.  Two HLA Class II Gene Variants Are Independently Associated with Pediatric Osteosarcoma Risk.

Authors:  Chenan Zhang; Joseph L Wiemels; Helen M Hansen; Julio Gonzalez-Maya; Alyson A Endicott; Adam J de Smith; Ivan V Smirnov; John S Witte; Libby M Morimoto; Catherine Metayer; Kyle M Walsh
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-07-23       Impact factor: 4.254

7.  HLA polymorphism and risk of multiple myeloma.

Authors:  Meral Beksac; Loren Gragert; Stephanie Fingerson; Martin Maiers; Mei-Jie Zhang; Mark Albrecht; Xiaobo Zhong; Wendy Cozen; Angela Dispenzieri; Sagar Lonial; Parameswaran Hari
Journal:  Leukemia       Date:  2016-07-27       Impact factor: 11.528

8.  Single haplotype admixture models using large scale HLA genotype frequencies to reproduce human admixture.

Authors:  Alexandra Litinsky Simanovsky; Abeer Madbouly; Michael Halagan; Martin Maiers; Yoram Louzoun
Journal:  Immunogenetics       Date:  2019-11-18       Impact factor: 2.846

9.  HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes.

Authors:  Sophia S Wang; Mary Carrington; Sonja I Berndt; Susan L Slager; Paige M Bracci; Jenna Voutsinas; James R Cerhan; Karin E Smedby; Henrik Hjalgrim; Joseph Vijai; Lindsay M Morton; Roel Vermeulen; Ora Paltiel; Claire M Vajdic; Martha S Linet; Alexandra Nieters; Silvia de Sanjose; Wendy Cozen; Elizabeth E Brown; Jennifer Turner; John J Spinelli; Tongzhang Zheng; Brenda M Birmann; Christopher R Flowers; Nikolaus Becker; Elizabeth A Holly; Eleanor Kane; Dennis Weisenburger; Marc Maynadie; Pierluigi Cocco; Demetrius Albanes; Stephanie J Weinstein; Lauren R Teras; W Ryan Diver; Stephanie J Lax; Ruth C Travis; Rudolph Kaaks; Elio Riboli; Yolanda Benavente; Paul Brennan; James McKay; Marie-Hélène Delfau-Larue; Brian K Link; Corrado Magnani; Maria Grazia Ennas; Giancarlo Latte; Andrew L Feldman; Nicole Wong Doo; Graham G Giles; Melissa C Southey; Roger L Milne; Kenneth Offit; Jacob Musinsky; Alan A Arslan; Mark P Purdue; Hans-Olov Adami; Mads Melbye; Bengt Glimelius; Lucia Conde; Nicola J Camp; Martha Glenn; Karen Curtin; Jacqueline Clavel; Alain Monnereau; David G Cox; Hervé Ghesquières; Gilles Salles; Paulo Bofetta; Lenka Foretova; Anthony Staines; Scott Davis; Richard K Severson; Qing Lan; Angela Brooks-Wilson; Martyn T Smith; Eve Roman; Anne Kricker; Yawei Zhang; Peter Kraft; Stephen J Chanock; Nathaniel Rothman; Patricia Hartge; Christine F Skibola
Journal:  Cancer Res       Date:  2018-05-07       Impact factor: 13.312

10.  HLA Associations and Risk of Posttransplant Lymphoproliferative Disorder in a Danish Population-Based Cohort.

Authors:  Maja Ølholm Vase; Eva Futtrup Maksten; Charlotte Strandhave; Esben Søndergaard; Knud Bendix; Stephen Hamilton-Dutoit; Claus Andersen; Michael Boe Møller; Søren Schwartz Sørensen; Jan Kampmann; Hans Eiskjær; Martin Iversen; Ilse Duus Weinreich; Bjarne Møller; Bente Jespersen; Francesco d'Amore
Journal:  Transplant Direct       Date:  2015-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.